Plasma zinc concentrations during the first 2 years after diagnosis of insulin-dependent diabetes mellitus: a prospective study.
Studies of zinc status in insulin-dependent diabetes mellitus (IDDM) have shown contradictory results. Zinc is essential for many enzymes involved in the human metabolism and may play a role in the biosynthesis and storage of insulin in the B-cell. We therefore prospectively followed 26 patients (14 males and 12 females) with newly diagnosed IDDM in order to determine the plasma zinc variation at the time of diagnosis and after 1, 3, 6, 12 and 24 months. Seventy-two healthy persons (36 males and 36 females) served as controls. Only minor differences in plasma zinc were demonstrated during the first 2 years of IDDM. A sex difference was found in healthy controls but only after 24 months in the diabetics. Quantitative changes of the B-cell function, development of insulin antibodies, age, body weight and serum albumin did not correlate with the course of plasma zinc.
Melchior
T
T
Steno Memorial Hospital, Gentofte, Denmark.
Simonsen
K W
KW
Johannessen
A C
AC
Binder
C
C
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001835:Body Weight; D002096:C-Peptide / Q000032:analysis; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000175:diagnosis; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007330:Insulin Antibodies / Q000032:analysis; D007515:Islets of Langerhans / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012709:Serum Albumin / Q000032:analysis; D012737:Sex Factors; D015032:Zinc / Q000097:blood*
D002096:C-Peptide; D006442:Glycated Hemoglobin; D007330:Insulin Antibodies; D012709:Serum Albumin; D015032:Zinc